190 related articles for article (PubMed ID: 25484205)
1. Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1.
Stead MA; Wright SC
Acta Crystallogr F Struct Biol Commun; 2014 Dec; 70(Pt 12):1591-6. PubMed ID: 25484205
[TBL] [Abstract][Full Text] [Related]
2. Targeting oncogenic transcriptional corepressor Nac1 POZ domain with conformationally constrained peptides by cyclization and stapling.
Wu T; He P; Wu W; Chen Y; Lv F
Bioorg Chem; 2018 Oct; 80():1-10. PubMed ID: 29864683
[TBL] [Abstract][Full Text] [Related]
3. Nac1 interacts with the POZ-domain transcription factor, Miz1.
Stead MA; Wright SC
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24702277
[TBL] [Abstract][Full Text] [Related]
4. Structure of the human Nac1 POZ domain.
Stead MA; Carr SB; Wright SC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May; 65(Pt 5):445-9. PubMed ID: 19407373
[TBL] [Abstract][Full Text] [Related]
5. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
6. NAC1, a POZ/BTB protein that functions as a corepressor.
Korutla L; Wang P; Jackson TG; Mackler SA
Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354
[TBL] [Abstract][Full Text] [Related]
7. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
8. Structure of the wild-type human BCL6 POZ domain.
Stead MA; Rosbrook GO; Hadden JM; Trinh CH; Carr SB; Wright SC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Dec; 64(Pt 12):1101-4. PubMed ID: 19052359
[TBL] [Abstract][Full Text] [Related]
9. A beta-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain.
Stead MA; Trinh CH; Garnett JA; Carr SB; Baron AJ; Edwards TA; Wright SC
J Mol Biol; 2007 Nov; 373(4):820-6. PubMed ID: 17880999
[TBL] [Abstract][Full Text] [Related]
10. Identification of an atypical interaction site in the BTB domain of the MYC-interacting zinc-finger protein 1.
Orth B; Sander B; Möglich A; Diederichs K; Eilers M; Lorenz S
Structure; 2021 Nov; 29(11):1230-1240.e5. PubMed ID: 34186024
[TBL] [Abstract][Full Text] [Related]
11. Backbone resonance assignment of the BCL6-BTB/POZ domain.
Lin LY; Evans SE; Fairall L; Schwabe JWR; Wagner SD; Muskett FW
Biomol NMR Assign; 2018 Apr; 12(1):47-50. PubMed ID: 28929458
[TBL] [Abstract][Full Text] [Related]
12. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
13. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain.
Evans SE; Goult BT; Fairall L; Jamieson AG; Ko Ferrigno P; Ford R; Schwabe JW; Wagner SD
PLoS One; 2014; 9(3):e90889. PubMed ID: 24595451
[TBL] [Abstract][Full Text] [Related]
14. Insights into strand exchange in BTB domain dimers from the crystal structures of FAZF and Miz1.
Stogios PJ; Cuesta-Seijo JA; Chen L; Pomroy NC; Privé GG
J Mol Biol; 2010 Jul; 400(5):983-97. PubMed ID: 20493880
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
Deltour S; Guerardel C; Leprince D
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6.
Dean J; Hashimoto K; Tsuji T; Gautier V; Hall WW; Sheehy N
Oncogene; 2009 Oct; 28(42):3723-34. PubMed ID: 19701248
[TBL] [Abstract][Full Text] [Related]
17. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
[TBL] [Abstract][Full Text] [Related]
18. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R
J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182
[TBL] [Abstract][Full Text] [Related]
19. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.
Pero R; Palmieri D; Angrisano T; Valentino T; Federico A; Franco R; Lembo F; Klein-Szanto AJ; Del Vecchio L; Montanaro D; Keller S; Arra C; Papadopoulou V; Wagner SD; Croce CM; Fusco A; Chiariotti L; Fedele M
J Biol Chem; 2012 May; 287(22):18308-17. PubMed ID: 22493480
[TBL] [Abstract][Full Text] [Related]
20. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.
Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
